We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-3.77%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.97B
AUM Growth
-$162M
Cap. Flow
+$11.8M
Cap. Flow %
0.4%
Top 10 Hldgs %
30.79%
Holding
836
New
124
Increased
242
Reduced
227
Closed
121
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
676
Tandem Diabetes Care
TNDM
$1.17B
$200K 0.01%
+1,720
New +$201K
UNIT
677
Uniti Group
UNIT
$2.7B
$183K 0.01%
+13,287
New +$168K
VTRS icon
678
Viatris
VTRS
$20.1B
$181K 0.01%
16,591
-292
-2% -$3.85K
BBVA icon
679
Banco Bilbao Vizcaya Argentaria
BBVA
$143B
$176K 0.01%
30,924
-3,481
-10% -$21.3K
HOUS
680
DELISTED
Anywhere Real Estate
HOUS
$171K 0.01%
+10,900
New +$182K
NMR icon
681
Nomura Holdings
NMR
$28.8B
$171K 0.01%
+40,431
New +$183K
SCTL
682
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$160K 0.01%
+89,063
New +$154K
NXTC icon
683
NextCure
NXTC
$16.8M
$149K 0.01%
+2,550
New +$160K
SHO icon
684
Sunstone Hotel Investors
SHO
$2.2B
$141K ﹤0.01%
12,000
-4,100
-25% -$46.6K
LIAN
685
DELISTED
LianBio American Depositary Shares
LIAN
$137K ﹤0.01%
+36,900
New +$152K
NHS
686
Neuberger High Yield Strategies Fund Inc
NHS
$251M
$124K ﹤0.01%
10,839
AMPY icon
687
Amplify Energy
AMPY
$163M
$114K ﹤0.01%
+20,700
New +$95.6K
JRSH icon
688
Jerash Holdings
JRSH
$58.8M
$114K ﹤0.01%
+17,700
New +$118K
RWT
689
Redwood Trust
RWT
$625M
$112K ﹤0.01%
10,667
-21,376
-67% -$243K
UTI icon
690
Universal Technical Institute
UTI
$2.08B
$112K ﹤0.01%
+12,600
New +$103K
LBPH
691
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$110K ﹤0.01%
+21,200
New +$101K
ELDN icon
692
Eledon Pharmaceuticals
ELDN
$273M
$109K ﹤0.01%
+27,600
New +$107K
AFMD
693
DELISTED
Affimed
AFMD
$108K ﹤0.01%
+2,460
New +$107K
SPRY icon
694
ARS Pharmaceuticals
SPRY
$604M
$106K ﹤0.01%
30,265
-1,735
-5% -$7.55K
CFRX
695
DELISTED
ContraFect Corporation
CFRX
$105K ﹤0.01%
+359
New +$87.3K
HROW icon
696
Harrow
HROW
$1.44B
$104K ﹤0.01%
+15,322
New +$118K
LINC icon
697
Lincoln Educational Services
LINC
$1.29B
$100K ﹤0.01%
+14,000
New +$101K
VYNE icon
698
VYNE Therapeutics
VYNE
$17.1M
$91K ﹤0.01%
+7,743
New +$92K
CTIC
699
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$89K ﹤0.01%
+19,000
New +$56.7K
MNOV icon
700
MediciNova
MNOV
$65.5M
$75K ﹤0.01%
+28,222
New +$69.1K

Similar funds

Bailard's Q1 2022 Portfolio in Review

As of Q1 2022, Bailard held 836 positions worth $2.97B, down 5.2% from $3.14B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bailard's Q1 2022 filing shows 124 new, 242 increased, 227 reduced and 121 closed positions. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 107,344 shares worth $3.96M. The largest sale was iShares Russell 2000 Value ETF, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q1 2022 buy was iShares MSCI Intl Quality Factor ETF: 107,344 shares worth $3.96M.
  • Bailard added most to SPDR Gold Trust in Q1 2022, an estimated $76.8M increase.
  • Bailard's biggest Q1 2022 reduction was iShares Russell 2000 Value ETF, cutting an estimated $80.2M.
  • Bailard fully exited Akamai in Q1 2022, selling an estimated $5.01M.
  • Bailard's ten largest holdings make up 31% of its $2.97B portfolio in Q1 2022.
  • Bailard opened 124 new positions and closed 121 in Q1 2022.
  • Bailard's portfolio value fell 5.2% quarter-over-quarter to $2.97B.

Based on Bailard's 13F filing for Q1 2022, filed 25 Apr 2022.